MAD2L2 and diabetes mellitus: In addition, podocyte-specific MAD2B deletion in mice reversed the diabetes-induced decline of Nephrin (a podocyte marker protein) expression (Figure 3G) and loss of podocytes by observing WT 1-positive cells (Figure 3H-I).